TY - JOUR
T1 - Clinical impact of Sim & Size® simulation software in the treatment of patients with cerebral aneurysms with flow-diverter Pipeline stents
AU - Mantilla, Daniel
AU - Ferreira-Prada, Carlos A.
AU - Galvis, Melquisedec
AU - Vargas, Oliverio
AU - Valenzuela-Santos, Carolina
AU - Canci, Piergiorgio
AU - Ochoa Vera, Miguel Enrique
AU - Ochoa, Miguel
AU - Nicoud, Franck
AU - Costalat, Vincent
N1 - Publisher Copyright:
© The Author(s) 2021.
PY - 2023/2
Y1 - 2023/2
N2 - Objectives: This study evaluated the clinical impact of the Sim&Size® simulation software on the endovascular treatment with flow-diverter stents of patients with unruptured saccular intracranial aneurysms. Methods: This monocentric retrospective study evaluated a cohort of patients treated with flow-divert stents between June 1, 2014, and December 31, 2019, for cerebral aneurysms. Patients belonged to two groups, patients treated with and without the Sim&Size® simulation software. Univariate, bivariate, and multivariate analyses were used to evaluate the clinical impact of simulation software. Results: Out of the 73 interventions involving 68 patients analyzed by the study, 76.7% were simulated using the Sim&Size® simulation software, and 23.3% were not. Patients treated with the simulation software had shorter stent lengths (16.00 mm vs. 20.00 mm p-value = 0.001) and surgical time (100.00 min vs. 118.00 min p-value = 0.496). Also, fewer of them required more than one stent (3.6% vs. 17.6% p-value = 0.079). Three patients belonging to the non-stimulated group presented hemorrhagic complications. Conclusions: Using the Sim&Size® simulation software for the endovascular treatment of intracranial aneurysms with pipeline flow-diverter stents reduces the stent length. © The Author(s) 2021.
AB - Objectives: This study evaluated the clinical impact of the Sim&Size® simulation software on the endovascular treatment with flow-diverter stents of patients with unruptured saccular intracranial aneurysms. Methods: This monocentric retrospective study evaluated a cohort of patients treated with flow-divert stents between June 1, 2014, and December 31, 2019, for cerebral aneurysms. Patients belonged to two groups, patients treated with and without the Sim&Size® simulation software. Univariate, bivariate, and multivariate analyses were used to evaluate the clinical impact of simulation software. Results: Out of the 73 interventions involving 68 patients analyzed by the study, 76.7% were simulated using the Sim&Size® simulation software, and 23.3% were not. Patients treated with the simulation software had shorter stent lengths (16.00 mm vs. 20.00 mm p-value = 0.001) and surgical time (100.00 min vs. 118.00 min p-value = 0.496). Also, fewer of them required more than one stent (3.6% vs. 17.6% p-value = 0.079). Three patients belonging to the non-stimulated group presented hemorrhagic complications. Conclusions: Using the Sim&Size® simulation software for the endovascular treatment of intracranial aneurysms with pipeline flow-diverter stents reduces the stent length. © The Author(s) 2021.
KW - Artificial Intelligence
KW - Computer Simulation
KW - Endovascular Procedures
KW - Flow-Diverter Devices
KW - Intracranial Aneurysm
KW - Pipeline Embolization Device
KW - Artificial Intelligence
KW - Computer Simulation
KW - Endovascular Procedures
KW - Flow-Diverter Devices
KW - Intracranial Aneurysm
KW - Pipeline Embolization Device
UR - http://www.scopus.com/inward/record.url?scp=85122139037&partnerID=8YFLogxK
U2 - 10.1177/15910199211068668
DO - 10.1177/15910199211068668
M3 - Artículo Científico
AN - SCOPUS:85122139037
SN - 1591-0199
VL - 29
SP - 47
EP - 55
JO - Interventional Neuroradiology
JF - Interventional Neuroradiology
IS - 1
ER -
